EMEA (Europe, Middle East and Africa) Rosiglitazone Market Report 2017

August 2017 | 102 pages | ID: E475222A360EN
QYResearch

Abstracts

In this report, the EMEA Rosiglitazone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Rosiglitazone for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rosiglitazone market competition by top manufacturers/players, with Rosiglitazone sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• SB Pharmco
• Teva
• Sandoz
• Hikma Pharms
• Dr Reddys Labs Inc
• Watson Labs
• Roxane
• Mylan Pharma

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• 1 mg
• 2 mg
• 4 mg
• 8 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rosiglitazone for each application, including

• Hospital
• Pharmacy
• Clinics

Contents

EMEA (Europe, Middle East and Africa) Rosiglitazone Market Report 2017

1 ROSIGLITAZONE OVERVIEW

1.1 Product Overview and Scope of Rosiglitazone
1.2 Classification of Rosiglitazone
  1.2.1 EMEA Rosiglitazone Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Rosiglitazone Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 1 mg
  1.2.4 2 mg
  1.2.5 4 mg
  1.2.6 8 mg
1.3 EMEA Rosiglitazone Market by Application/End Users
  1.3.1 EMEA Rosiglitazone Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Clinics
1.4 EMEA Rosiglitazone Market by Region
  1.4.1 EMEA Rosiglitazone Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Rosiglitazone (2012-2022)
  1.5.1 EMEA Rosiglitazone Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Rosiglitazone Revenue and Growth Rate (2012-2022)

2 EMEA ROSIGLITAZONE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Rosiglitazone Market Competition by Players/Manufacturers
  2.1.1 EMEA Rosiglitazone Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Rosiglitazone Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Rosiglitazone Sale Price by Players (2012-2017)
2.2 EMEA Rosiglitazone (Volume and Value) by Type/Product Category
  2.2.1 EMEA Rosiglitazone Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Rosiglitazone Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Rosiglitazone Sale Price by Type (2012-2017)
2.3 EMEA Rosiglitazone (Volume) by Application
2.4 EMEA Rosiglitazone (Volume and Value) by Region
  2.4.1 EMEA Rosiglitazone Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Rosiglitazone Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Rosiglitazone Sales Price by Region (2012-2017)

3 EUROPE ROSIGLITAZONE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Rosiglitazone Sales and Value (2012-2017)
  3.1.1 Europe Rosiglitazone Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Rosiglitazone Revenue and Growth Rate (2012-2017)
3.2 Europe Rosiglitazone Sales and Market Share by Type
3.3 Europe Rosiglitazone Sales and Market Share by Application
3.4 Europe Rosiglitazone Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Rosiglitazone Sales Volume by Countries (2012-2017)
  3.4.2 Europe Rosiglitazone Revenue by Countries (2012-2017)
  3.4.3 Germany Rosiglitazone Sales and Growth Rate (2012-2017)
  3.4.4 France Rosiglitazone Sales and Growth Rate (2012-2017)
  3.4.5 UK Rosiglitazone Sales and Growth Rate (2012-2017)
  3.4.6 Russia Rosiglitazone Sales and Growth Rate (2012-2017)
  3.4.7 Italy Rosiglitazone Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Rosiglitazone Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ROSIGLITAZONE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Rosiglitazone Sales and Value (2012-2017)
  4.1.1 Middle East Rosiglitazone Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Rosiglitazone Revenue and Growth Rate (2012-2017)
4.2 Middle East Rosiglitazone Sales and Market Share by Type
4.3 Middle East Rosiglitazone Sales and Market Share by Application
4.4 Middle East Rosiglitazone Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Rosiglitazone Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Rosiglitazone Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Rosiglitazone Sales and Growth Rate (2012-2017)
  4.4.4 Israel Rosiglitazone Sales and Growth Rate (2012-2017)
  4.4.5 UAE Rosiglitazone Sales and Growth Rate (2012-2017)
  4.4.6 Iran Rosiglitazone Sales and Growth Rate (2012-2017)

5 AFRICA ROSIGLITAZONE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Rosiglitazone Sales and Value (2012-2017)
  5.1.1 Africa Rosiglitazone Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Rosiglitazone Revenue and Growth Rate (2012-2017)
5.2 Africa Rosiglitazone Sales and Market Share by Type
5.3 Africa Rosiglitazone Sales and Market Share by Application
5.4 Africa Rosiglitazone Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Rosiglitazone Sales Volume by Countries (2012-2017)
  5.4.2 Africa Rosiglitazone Revenue by Countries (2012-2017)
  5.4.3 South Africa Rosiglitazone Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Rosiglitazone Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Rosiglitazone Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Rosiglitazone Sales and Growth Rate (2012-2017)

6 EMEA ROSIGLITAZONE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 SB Pharmco
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rosiglitazone Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 SB Pharmco Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Teva
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Rosiglitazone Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Teva Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sandoz
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Rosiglitazone Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sandoz Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hikma Pharms
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Rosiglitazone Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hikma Pharms Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dr Reddys Labs Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Rosiglitazone Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dr Reddys Labs Inc Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Watson Labs
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Rosiglitazone Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Watson Labs Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Roxane
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Rosiglitazone Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Roxane Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mylan Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Rosiglitazone Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mylan Pharma Rosiglitazone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ROSIGLITAZONE MANUFACTURING COST ANALYSIS

7.1 Rosiglitazone Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rosiglitazone

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rosiglitazone Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rosiglitazone Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ROSIGLITAZONE MARKET FORECAST (2017-2022)

11.1 EMEA Rosiglitazone Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Rosiglitazone Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Rosiglitazone Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Rosiglitazone Price and Trend Forecast (2017-2022)
11.2 EMEA Rosiglitazone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Rosiglitazone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Rosiglitazone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Rosiglitazone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Rosiglitazone Sales Forecast by Type (2017-2022)
11.7 EMEA Rosiglitazone Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rosiglitazone
Figure EMEA Rosiglitazone Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Rosiglitazone Sales Volume Market Share by Type (Product Category) in 2016
Figure 1 mg Product Picture
Figure 2 mg Product Picture
Figure 4 mg Product Picture
Figure 8 mg Product Picture
Figure EMEA Rosiglitazone Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Rosiglitazone by Application in 2016
Figure Hospital Examples
Figure Pharmacy Examples
Figure Clinics Examples
Figure EMEA Rosiglitazone Market Size (Million USD) by Region (2012-2022)
Figure Europe Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Rosiglitazone Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Rosiglitazone Revenue (Million USD) Status and Forecast by Countries
Figure Africa Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Rosiglitazone Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Rosiglitazone Sales Volume and Growth Rate (2012-2022)
Figure EMEA Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Rosiglitazone Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Rosiglitazone Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Rosiglitazone Sales Share by Players (2012-2017)
Figure 2016 Rosiglitazone Sales Share by Players
Figure 2017 Rosiglitazone Sales Share by Players
Figure EMEA Rosiglitazone Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Rosiglitazone Revenue (Million USD) by Players (2012-2017)
Table EMEA Rosiglitazone Revenue Share by Players (2012-2017)
Table 2016 EMEA Rosiglitazone Revenue Share by Players
Table 2017 EMEA Rosiglitazone Revenue Share by Players
Table EMEA Rosiglitazone Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Rosiglitazone Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Rosiglitazone Sales Share by Type (2012-2017)
Figure Sales Market Share of Rosiglitazone by Type (2012-2017)
Figure EMEA Rosiglitazone Sales Market Share by Type (2012-2017)
Table EMEA Rosiglitazone Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Rosiglitazone Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rosiglitazone by Type in 2016
Table EMEA Rosiglitazone Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Rosiglitazone Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Rosiglitazone Sales Share by Application (2012-2017)
Figure Sales Market Share of Rosiglitazone by Application (2012-2017)
Figure EMEA Rosiglitazone Sales Market Share by Application in 2016
Table EMEA Rosiglitazone Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Rosiglitazone Sales Share by Region (2012-2017)
Figure Sales Market Share of Rosiglitazone by Region (2012-2017)
Figure EMEA Rosiglitazone Sales Market Share in 2016
Table EMEA Rosiglitazone Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Rosiglitazone Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Rosiglitazone by Region (2012-2017)
Figure EMEA Rosiglitazone Revenue Market Share Regions in 2016
Table EMEA Rosiglitazone Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Rosiglitazone Revenue and Growth Rate (2012-2017)
Table Europe Rosiglitazone Sales (K Units) by Type (2012-2017)
Table Europe Rosiglitazone Market Share by Type (2012-2017)
Figure Europe Rosiglitazone Market Share by Type in 2016
Table Europe Rosiglitazone Sales (K Units) by Application (2012-2017)
Table Europe Rosiglitazone Market Share by Application (2012-2017)
Figure Europe Rosiglitazone Market Share by Application in 2016
Table Europe Rosiglitazone Sales (K Units) by Countries (2012-2017)
Table Europe Rosiglitazone Sales Market Share by Countries (2012-2017)
Figure Europe Rosiglitazone Sales Market Share by Countries (2012-2017)
Figure Europe Rosiglitazone Sales Market Share by Countries in 2016
Table Europe Rosiglitazone Revenue (Million USD) by Countries (2012-2017)
Table Europe Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Europe Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Europe Rosiglitazone Revenue Market Share by Countries in 2016
Figure Germany Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure France Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure UK Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Rosiglitazone Sales (K Units) by Type (2012-2017)
Table Middle East Rosiglitazone Market Share by Type (2012-2017)
Figure Middle East Rosiglitazone Market Share by Type (2012-2017)
Table Middle East Rosiglitazone Sales (K Units) by Applications (2012-2017)
Table Middle East Rosiglitazone Market Share by Applications (2012-2017)
Figure Middle East Rosiglitazone Sales Market Share by Application in 2016
Table Middle East Rosiglitazone Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Rosiglitazone Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Rosiglitazone Sales Volume Market Share by Countries in 2016
Table Middle East Rosiglitazone Revenue (Million USD) by Countries (2012-2017)
Table Middle East Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Middle East Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Middle East Rosiglitazone Revenue Market Share by Countries in 2016
Figure Saudi Arabia Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rosiglitazone Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Rosiglitazone Sales (K Units) by Type (2012-2017)
Table Africa Rosiglitazone Sales Market Share by Type (2012-2017)
Figure Africa Rosiglitazone Sales Market Share by Type (2012-2017)
Figure Africa Rosiglitazone Sales Market Share by Type in 2016
Table Africa Rosiglitazone Sales (K Units) by Application (2012-2017)
Table Africa Rosiglitazone Sales Market Share by Application (2012-2017)
Figure Africa Rosiglitazone Sales Market Share by Application (2012-2017)
Table Africa Rosiglitazone Sales Volume (K Units) by Countries (2012-2017)
Table Africa Rosiglitazone Sales Market Share by Countries (2012-2017)
Figure Africa Rosiglitazone Sales Market Share by Countries (2012-2017)
Figure Africa Rosiglitazone Sales Market Share by Countries in 2016
Table Africa Rosiglitazone Revenue (Million USD) by Countries (2012-2017)
Table Africa Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Africa Rosiglitazone Revenue Market Share by Countries (2012-2017)
Figure Africa Rosiglitazone Revenue Market Share by Countries in 2016
Figure South Africa Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Table SB Pharmco Rosiglitazone Basic Information List
Table SB Pharmco Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SB Pharmco Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure SB Pharmco Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure SB Pharmco Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Teva Rosiglitazone Basic Information List
Table Teva Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Teva Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Sandoz Rosiglitazone Basic Information List
Table Sandoz Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Sandoz Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Sandoz Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Hikma Pharms Rosiglitazone Basic Information List
Table Hikma Pharms Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hikma Pharms Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Hikma Pharms Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Hikma Pharms Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Dr Reddys Labs Inc Rosiglitazone Basic Information List
Table Dr Reddys Labs Inc Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Dr Reddys Labs Inc Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Watson Labs Rosiglitazone Basic Information List
Table Watson Labs Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Watson Labs Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Watson Labs Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Watson Labs Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Roxane Rosiglitazone Basic Information List
Table Roxane Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roxane Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Roxane Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Roxane Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Mylan Pharma Rosiglitazone Basic Information List
Table Mylan Pharma Rosiglitazone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Pharma Rosiglitazone Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan Pharma Rosiglitazone Sales Market Share in EMEA (2012-2017)
Figure Mylan Pharma Rosiglitazone Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rosiglitazone
Figure Manufacturing Process Analysis of Rosiglitazone
Figure Rosiglitazone Industrial Chain Analysis
Table Raw Materials Sources of Rosiglitazone Major Manufacturers in 2016
Table Major Buyers of Rosiglitazone
Table Distributors/Traders List
Figure EMEA Rosiglitazone Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Rosiglitazone Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Rosiglitazone Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Rosiglitazone Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Rosiglitazone Sales Market Share Forecast by Region (2017-2022)
Table EMEA Rosiglitazone Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Rosiglitazone Revenue Market Share Forecast by Region (2017-2022)
Table Europe Rosiglitazone Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Rosiglitazone Sales Market Share Forecast by Countries (2017-2022)
Table Europe Rosiglitazone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Rosiglitazone Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Rosiglitazone Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Rosiglitazone Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Rosiglitazone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Rosiglitazone Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Rosiglitazone Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Rosiglitazone Sales Market Share Forecast by Countries (2017-2022)
Table Africa Rosiglitazone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Rosiglitazone Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Rosiglitazone Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Rosiglitazone Sales Market Share Forecast by Type (2017-2022)
Table EMEA Rosiglitazone Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Rosiglitazone Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources